Luke Dannenberg
Luke Dannenberg
Luke has >18 years of global industry experience in life sciences and diagnostics, with a focus on nucleic acid technologies and solutions. Luke joined Oligo Factory in January 2025 from Dana-Farber Cancer Institute (DFCI) where he served as the Accelerator Business Development Director for Diagnostics and led the commercialization of the oncology diagnostics technologies invented at DFCI.
Prior to DFCI, Luke served in multiple leadership positions within Roche’s Diagnostics division, including Lifecycle Leader for the Tissue CDx portfolio at Foundation Medicine, Lifecycle Leader and International Business Leader for the NGS Sample Prep Reagents portfolio at Roche Sequencing Solutions. Luke has also worked abroad with Roche Diagnostics Middle East as Head of Marketing, Gulf-Levant Region in Amman, Jordan and as Product Manager, Applied Science in Dubai, UAE. He started his industry career in 2006 at NimbleGen Systems just prior to its acquisition by Roche in 2007, where he held roles in product management, business development and project management.
Luke holds a Ph.D. in Biochemistry from the Indiana University School of Medicine and a B.Sc. in Molecular Biology from the University of Wisconsin-La Crosse.
